Prescription drug · ANDA
Sevelamer carbonate NDC 68475-010
Sevelamer carbonate 800 mg/1 · Tablet, Film coated · Oral · Navinta LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 68475-010-01 | 68475001001 | 30 TABLET, FILM COATED in 1 BOTTLE (68475-010-01)Marketed from Nov 1, 2025 | |
| 68475-010-02 | 68475001002 | 270 TABLET, FILM COATED in 1 BOTTLE (68475-010-02)Marketed from Nov 1, 2025 | |
| 68475-010-03 | 68475001003 | 180 TABLET, FILM COATED in 1 BOTTLE (68475-010-03)Marketed from Jan 2, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Sevelamer carbonate
- Generic name (nonproprietary)
- sevelamer carbonate
- Active ingredients
- Sevelamer carbonate — 800 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- Navinta LLC
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 219931
- Marketing start
- Listing expires
- Other FDA classes
- Phosphate Chelating Activity (Mechanism)
- Identifiers
- Product ID 68475-010_d3c74ca1-7175-40a4-b96f-f864b7f47846SPL ID d3c74ca1-7175-40a4-b96f-f864b7f47846SPL set ID d2f0c283-3e9d-41db-bd4d-83bd21f2a019RxCUI 749206UNII 9YCX42I8IUUPC 0368475010017, 0368475010024, 0368475010031
- Pharmacologic class
- Phosphate Binder
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N468475001001followed by a unit qualifier and the quantityPackage 68475-0010-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Sevelamer carbonate tablets are indicated for the control of serum phosphorus in adults and children 6 years of age and older with chronic kidney disease (CKD) on dialysis. Sevelamer carbonate tablets are a phosphate binder indicated for the control of serum phosphorus in adults and children 6 years of age and older with chronic kidney disease on dialysis.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 219931
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Sevelamer carbonate | Sevelamer carbonate 800 mg/1 | Tablet, Film coatedOral | Zydus Pharmaceuticals USA Inc. | 70710-2170 |